Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.
Here’s how you can take action to support rectal microbicide research.
The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.
Scientists have made progress developing such a microbicide, with promising results in tests among monkeys.
What does the future hold for new pre-exposure prophylaxis (PrEP) against HIV, including long-acting injectables and less toxic drugs?
Jim Pickett of AIDS Foundation Chicago presents the latest research on rectal microbicides.
Despite efforts to promote sex education and condom use, HIV rates are not declining.
Rectal microbicides-topical gels, ointments and lubricants laced with drugs to block HIV-could help stop the spread of the virus. So why...
Years ago, when I went to my first HIV doctor’s appointment, he reviewed a list of specific sexual activities in an effort to ascertain...
University of Pittsburgh researcher Ian McGowan, MD, has received two grants from the National Institutes of Health (NIH) totaling $17.5 milli...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.